Literature DB >> 7252563

The distribution of skeletal metastases in breast and pulmonary cancer: concise communication.

M A Wilson, F W Calhoun.   

Abstract

In a review of all radionuclide bone scans performed in a 3-mo period, 318 patients with established tumor diagnosis were studied. In this tumor population the incidence of skeletal metastases was statistically similar (p = 0.7), and regional distribution of lesion involvement was, in decreasing order, thorax, spine, pelvis, limbs, and skull. In the two largest tumor groups (breast and lung) the regional distribution of metastases was not different when examined for both the presence and the number of lesions (p greater than 0.1). In particular, the incidence of rib metastases was similar( p greater than 0.99) as was their frequency distribution (0.78). Indeed, the frequency distribution of rib metastases was similar for all major tumor categories (p = 0.83).

Entities:  

Mesh:

Year:  1981        PMID: 7252563

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  14 in total

1.  Lung cancer underlying paravertebral abscess with intramedullary spinal cord metastases.

Authors:  Laura Iliescu; Letitia Toma
Journal:  BMJ Case Rep       Date:  2013-09-13

2.  Case report 272. Skeletal (predominately) cortical metastases in the left femur arising from bronchogenic carcinoma.

Authors:  A Greenspan; M J Klein; M M Lewis
Journal:  Skeletal Radiol       Date:  1984       Impact factor: 2.199

3.  Effect of Bone Reading CT software on radiologist performance in detecting bone metastases from breast cancer.

Authors:  Ji Y Ha; Kyung N Jeon; Kyungsoo Bae; Bong H Choi
Journal:  Br J Radiol       Date:  2017-03-03       Impact factor: 3.039

4.  Comparison of distribution characteristics of metastatic bone lesions between breast and prostate carcinomas.

Authors:  Chang-Yin Wang; Guang-Yao Wu; Mei-Juan Shen; Kun-Wei Cui; Ying Shen
Journal:  Oncol Lett       Date:  2012-10-30       Impact factor: 2.967

Review 5.  Diagnostic imaging to detect and evaluate response to therapy in bone metastases from prostate cancer: current modalities and new horizons.

Authors:  Laura Evangelista; Francesco Bertoldo; Francesco Boccardo; Giario Conti; Ilario Menchi; Francesco Mungai; Umberto Ricardi; Emilio Bombardieri
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-03-09       Impact factor: 9.236

6.  The development of bone metastases as the first sign of metastatic spread in patients with primary solid tumours.

Authors:  S A Papadakis; T C Mitsitsikas; S Markakidis; M K Minas; G Tripsiannis; A A Tentes
Journal:  Int Orthop       Date:  2003-12-17       Impact factor: 3.075

7.  Clinical Characteristics and Prognostic Factors in Bone Metastases from Lung Cancer.

Authors:  Li Zhang; Zhixin Gong
Journal:  Med Sci Monit       Date:  2017-08-24

8.  Genome-wide identification of bone metastasis-related microRNAs in lung adenocarcinoma by high-throughput sequencing.

Authors:  Lin Xie; Zuozhang Yang; Guoqi Li; Lida Shen; Xudong Xiang; Xuefeng Liu; Da Xu; Lei Xu; Yanjin Chen; Zhao Tian; Xin Chen
Journal:  PLoS One       Date:  2013-04-08       Impact factor: 3.240

9.  Distribution Features of Skeletal Metastases: A Comparative Study between Pulmonary and Prostate Cancers.

Authors:  Changyin Wang; Ying Shen; Shaobo Zhu
Journal:  PLoS One       Date:  2015-11-23       Impact factor: 3.240

10.  Serum dickkopf-1 as a clinical and prognostic factor in non-small cell lung cancer patients with bone metastases.

Authors:  Rong Qiao; Runbo Zhong; Qing Chang; Jiajun Teng; Jun Pei; Baohui Han; Tianqing Chu
Journal:  Oncotarget       Date:  2017-06-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.